NSE ScannerChemicals · Chemicals: Specialty · NSE: TRANSPEK · data 2026-10-31
Transpek Industry Limited
In plain words
Price: 17.2% below its 52-week high of ₹1,475.
Delivery: 48.6% of traded shares were kept for delivery over the last 10 sessions, against 65.0% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹618 cr |
| Net profit (last 12 months) | ₹39 cr |
| Sales growth, 3 years (yearly) | -9.1% |
| Profit growth, 3 years (yearly) | -18.2% |
At a glance
P/E 17.5, dividend yield 1.6%. Price relative to earnings and book value (low is cheaper, not better).
ROE 6.0%, ROCE 6.2%, operating margin 6.8%: how much profit it earns on the money it uses.
Debt/equity 0.10, Profit growth -18.2% and sales growth -9.1% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Low return on equity (6.0%).
- Profit fell 18.2% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend
- 7 Sept 26Dividend Dividend ₹20 (ex-date) -5.3% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Common questions
Is Transpek Industry Limited debt-free?
Its latest reported debt-to-equity ratio is 0.1.
What is Transpek Industry Limited's P/E ratio?
About 17.5, based on the last 12 months' earnings and a price of ₹1,221.1 (data 2026-10-31).
What is the 52-week high and low of Transpek Industry Limited?
The 52-week high is ₹1,475 and the 52-week low is ₹952.3.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Transpek Industry Limited | ₹1,221.1 | ₹690 cr | 17.5 | — | 6% | 6.2% | 0.1 | +7.5% |
| Kanoria Chemicals & Industries Ltd | ₹167.34 | ₹738 cr | 12.8 | — | 7.3% | 4.2% | 0.51 | +112.8% |
| Kronox Lab Sciences Limited | ₹186.26 | ₹698 cr | 24.2 | — | 26.8% | 31.6% | 0.01 | +22.8% |
| Sadhana Nitro Chem Limited | ₹2.25 | ₹682 cr | — | 1.5 | -23.5% | -13.9% | 0.25 | +14.6% |
| Chemcon Speciality Chemicals Ltd | ₹181.84 | ₹673 cr | 22.2 | 1.4 | 4.8% | 3.9% | 0.11 | -28.6% |
| Amal Ltd. | ₹532.65 | ₹660 cr | 22.1 | 4.7 | 20.4% | 23.5% | 0 | -30.1% |
Compare TRANSPEK with KANORICHEM in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open TRANSPEK in NSE Scanner →